Bing Center for Waldenstrom's Macroglobulinemia - Maintenance Rituximab is associated with improved clinical outcome in rituximab naı¨ve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

You are here: Home

Publications

Pub-2011

Maintenance Rituximab is associated with improved clinical outcome in rituximab naı¨ve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

Can't see this document? Click Here

Legal | Privacy